Shanxi Zhendong Pharmaceutical (300158) — Financial Flexibility Index
Shanxi Zhendong Pharmaceutical (300158) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of CN¥-146.66 Million (operating CF CN¥-197.94 Million minus capex CN¥51.28 Million) represents 0% of total liabilities (CN¥882.65 Million). Check 300158 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanxi Zhendong Pharmaceutical Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Shanxi Zhendong Pharmaceutical across 18 annual periods. For the full cash flow conversion analysis, see Shanxi Zhendong Pharmaceutical (300158) cash flow conversion.
Annual Financial Flexibility Index for Shanxi Zhendong Pharmaceutical (2007–2024)
Year-by-year free cash flow to debt coverage for Shanxi Zhendong Pharmaceutical. Explore Shanxi Zhendong Pharmaceutical (300158) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥148.65 Million | CN¥-149.82 Million | CN¥1.32 Billion | ▲ +258.0% |
| 2023 | -0.07x | CN¥-73.74 Million | CN¥-189.95 Million | CN¥1.04 Billion | ▼ -140.7% |
| 2022 | 0.17x | CN¥232.12 Million | CN¥86.31 Million | CN¥1.33 Billion | ▼ -18.3% |
| 2021 | 0.21x | CN¥436.11 Million | CN¥284.45 Million | CN¥2.04 Billion | ▲ +3.8% |
| 2020 | 0.21x | CN¥405.90 Million | CN¥221.94 Million | CN¥1.97 Billion | ▲ +47.6% |
| 2019 | 0.14x | CN¥205.72 Million | CN¥186.35 Million | CN¥1.47 Billion | ▲ +44.7% |
| 2018 | 0.10x | CN¥178.40 Million | CN¥154.48 Million | CN¥1.85 Billion | ▲ +113.1% |
| 2017 | 0.05x | CN¥93.02 Million | CN¥45.09 Million | CN¥2.06 Billion | ▼ -28.9% |
| 2016 | 0.06x | CN¥102.09 Million | CN¥-44.72 Million | CN¥1.60 Billion | ▼ -34.6% |
| 2015 | 0.10x | CN¥198.76 Million | CN¥151.84 Million | CN¥2.04 Billion | ▼ -60.2% |
| 2014 | 0.24x | CN¥217.38 Million | CN¥73.23 Million | CN¥888.23 Million | ▲ +28.0% |
| 2013 | 0.19x | CN¥160.32 Million | CN¥-75.04 Million | CN¥838.64 Million | ▼ -75.7% |
| 2012 | 0.79x | CN¥538.15 Million | CN¥189.40 Million | CN¥684.26 Million | ▲ +21.0% |
| 2011 | 0.65x | CN¥258.31 Million | CN¥-88.73 Million | CN¥397.40 Million | ▲ +124.8% |
| 2010 | 0.29x | CN¥112.49 Million | CN¥32.40 Million | CN¥389.13 Million | ▲ +16.8% |
| 2009 | 0.25x | CN¥70.29 Million | CN¥42.28 Million | CN¥283.87 Million | ▼ -8.9% |
| 2008 | 0.27x | CN¥62.53 Million | CN¥33.18 Million | CN¥229.98 Million | ▼ -53.8% |
| 2007 | 0.59x | CN¥170.72 Million | CN¥128.65 Million | CN¥290.28 Million | — |